MedTrace Logo

A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation

NCT04576130 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2025-01-27

No results posted yet for this study

Summary

DanICD is a randomized, controlled study to with the aim to assess whether there is a benefit of ICD-implantation in patients with coronary artery disease (including acute myocardial infarction), who survive cardiac arrest due to ventricular fibrillation/sustained ventricular tachycardia and undergo revascularization and with an LVEF above 35%.

Conditions

  • Coronary Artery Disease
  • Acute Myocardial Infarction
  • Ventricular Fibrillation
  • Ventricular Tachycardia, Sustained
  • Out-Of-Hospital Cardiac Arrest

Interventions

DEVICE

Implantable cardioverter defibrillator

Implantation of an ICD for secondary prevention

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Reza Jabbari, MD, PhD · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-12
Primary Completion
2032-10-31
Completion
2032-10-31
FDA Device
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04576130 on ClinicalTrials.gov